Position in ABBV
as of Mar 31, 2026
· filed Apr 2, 2026
Position Value
$11,309
-$572 QoQ
Shares Held
52
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Horizons Wealth Management holds $358,288 across 4 Drug Manufacturers - General names. ABBV ranks #3 (3.2% of the industry book) .
All Filings in ABBV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,309 | 52 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $11,881 | 52 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $12,040 | 52 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $9,652 | 52 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $10,895 | 52 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $9,240 | 52 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $10,268 | 52 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $8,919 | 52 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $9,469 | 52 | Shares | Sole | 2024-04-03 | |
| 2023-12-31 | $8,058 | 52 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $7,751 | 52 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $7,005 | 52 | Shares | Sole | 2023-07-03 | |
| 2023-03-31 | $4,940 | 31 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $5,009 | 31 | Shares | Sole | 2023-01-03 | |
| 2022-09-30 | $4,160 | 31 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $4,747 | 31 | Shares | Sole | 2022-08-19 | |
| No filing history on record for this holder in this stock. | ||||||